Stock AARTIDRUGS AARTI DRUGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Aarti Drugs Limited NSE India S.E.

Equities

AARTIDRUGS

INE767A01016

Delayed NSE India S.E.
Other stock markets
 03:13:35 29/05/2024 pm IST 		5-day change 1st Jan Change
486.8 INR -1.79% Intraday chart for Aarti Drugs Limited -1.89% -0.63%
06/05 Transcript : Aarti Drugs Limited, Q4 2024 Earnings Call, May 06, 2024
03/05 Aarti Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Aarti Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
Aarti Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2024
Aarti Drugs Limited Announces Executive Cessation
Aarti Drugs Begins Manufacturing Dermatology Products in Tarapur, India Facility
Aarti Drugs Limited Initiates Commercial Production of Dermatology Product At New Facility in Tarapur, Maharashtra
Aarti Drugs Limited Announces Interim Dividend for the Financial Year 2023- 24
Aarti Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Aarti Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Aarti Drugs Clocks Gains in Fiscal Q1 Consolidated Profit
Aarti Drugs Limited announces an Equity Buyback for 665,000 shares, representing 0.72% for INR 598.5 million.
Aarti Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Aarti Drugs Limited authorizes a Buyback Plan.
Aarti Drugs Limited's Board intends to launch an Equity Buyback on July 21, 2023.
Aarti Drugs Limited's Board intends to launch an Equity Buyback on July 21, 2023.
Aarti Drugs' Consolidated Profit Climbs in Fiscal Q4
Aarti Drugs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
Aarti Drugs' Consolidated Net Profit Declines in Fiscal Q3
Aarti Drugs Limited Declares Interim Dividend for the Financial Year 2022-23
Aarti Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
Aarti Drugs' Consolidated Profit Falls in Fiscal Q2
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AARTIDRUGS Stock
  4. AARTIDRUGS Stock
  5. News Aarti Drugs Limited
  6. Other languages